Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Cancer Geriatric Assessment and Technology Evaluation (ProsGATE) Study

NCT06215508 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT06215508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06215508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Cancer Geriatric Assessment and Technology Evaluation (ProsGATE) Study
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2026
Completion date
April 30, 2031
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostate cancer metastatic